Kirk Tousaw on the panel, “Legal and Ethics: Guidelines and Practical Tools for Therapists,” at the 2nd Annual Psychedelic Psychotherapy Forum
“After nearly forty years of prohibition, a new wave of research has emerged in the past decade exploring the efficacy of psychedelic substances (LSD, Ibogaine, Ayahuasca, MDMA, Psilocybin, and Cannabis) in the treatment of addictions, trauma, PTSD, end of life anxiety, and depression. This groundbreaking forum provides opportunities to engage with researchers, academics, and therapists from a variety...